Enhanced inhibitory signalling and modulation of immune responses are typical attributes of increased BTLA expression in T cells which may be present in moderate CFS/ME patients who have amplified expression of inhibitory receptor BTLA4 in central memory CD4+T cells [52]. Here, BTLA is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.